Speech-Language Pathologists in Palmyra, PA Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Jennifer Lynn Bear Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 734 E Oak St, Palmyra, PA 17078 Phone: 717-512-3560

Kimberly Moran, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 129 Sunflower Ln, Palmyra, PA 17078 Phone: 717-645-6293

Mrs. Catherine A. Roscoe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 950 E Pine St, Palmyra, PA 17078 Phone: 717-838-1231

Dr. Stacey Marie Soos, SLPD, CC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 609 Saddle Rd, Palmyra, PA 17078 Phone: 717-406-9433

Leah Elizabeth Hayward, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 106 Coventry Ct, Palmyra, PA 17078 Phone: 717-799-6757

Ashley Martz, MS ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 341 N Railroad St, Palmyra, PA 17078 Phone: 717-838-3011

Anne Boran Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2880 Horseshoe Pike, Palmyra, PA 17078 Phone: 717-838-2231

News Archive

New ‘nanotech' weapon against drug-resistant superbugs

Scientists at the Institute of Bioengineering and Nanotechnology (IBN) and IBM Research – Almaden have developed the first biodegradable polymer nanoparticles to combat drug-resistant superbugs, such as Methicillin-Resistant Staphylococcus aureus (MRSA). These nanoparticles can selectively kill the bacteria without destroying healthy red blood cells, and being biodegradable, have great potential to treat infectious diseases in the body. This was reported today in the leading scientific journal, Nature Chemistry [(2011) DOI: 10.1038/nchem.1012].

TSO3 second quarter revenues increase to $703,000

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings, posted its highest quarterly revenues in its second quarter of 2011.

ILAE's new epilepsy classification empowers clinicians and patients to make more informed treatment decisions

It has been nearly three decades since experts published a classification system related to epilepsy. Now, the International League Against Epilepsy (ILAE) provides an update to systems that includes many types of seizures not captured in the older version, allowing clinicians and patients to make more informed decisions concerning treatment.

Use of statins and beta-blockers as prescribed following heart attack associated with living longer

New research suggests that the pharmacological effects of taking medications such as statins and beta-blockers as prescribed following a heart attack is associated with living longer, according to a study in the January 10 issue of JAMA: The Journal of the American Medical Association.

Read more Medical News

› Verified 6 days ago